CUPR.US Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Healthcare Health Care Equipment & Supplies USA Stocks
2.20 USD
Close of Nov 14, 2026
1.45 8.41
Market cap
USD 12.9M
P/E
-
P/B
3.06x
ROE
-212.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is CUPR.US undervalued?

Graham number

The Graham number of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares fundamental analysis

No fundamental analysis for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares yet.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collage…

Full company profile